MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.
| Revenue (TTM) | $1.91B |
| Gross Profit (TTM) | $493.70M |
| EBITDA | $252.91M |
| Operating Margin | 11.10% |
| Return on Equity | 20.30% |
| Return on Assets | 6.57% |
| Revenue/Share (TTM) | $22.76 |
| Book Value | $10.68 |
| Price-to-Book | 2.08 |
| Price-to-Sales (TTM) | 0.94 |
| EV/Revenue | 1.012 |
| EV/EBITDA | 7.06 |
| Quarterly Earnings Growth (YoY) | 11.40% |
| Quarterly Revenue Growth (YoY) | -1.70% |
| Shares Outstanding | $83.07M |
| Float | $79.95M |
| % Insiders | 2.31% |
| % Institutions | 104.13% |